ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $221,092 | -58.9% | 6,200 | -70.8% | 0.00% | -87.5% |
| Q1 2023 | $538,480 | +63.9% | 21,200 | +161.7% | 0.01% | +33.3% |
| Q4 2022 | $328,536 | +50.0% | 8,100 | +30.4% | 0.01% | 0.0% |
| Q2 2022 | $219,000 | -79.8% | 6,213 | -73.6% | 0.01% | -79.3% |
| Q1 2022 | $1,083,000 | +310.2% | 23,543 | +491.5% | 0.03% | +93.3% |
| Q1 2021 | $264,000 | -82.5% | 3,980 | -83.3% | 0.02% | -84.7% |
| Q4 2019 | $1,509,000 | +110.8% | 23,800 | -6.3% | 0.10% | +127.9% |
| Q3 2019 | $716,000 | +244.2% | 25,400 | +124.8% | 0.04% | +22.9% |
| Q1 2019 | $208,000 | +14.9% | 11,300 | +20.0% | 0.04% | -58.3% |
| Q3 2018 | $181,000 | – | 9,416 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |